▶ 調査レポート

糖尿病治療器具の世界市場分析・規模・シェア・成長・動向・予測:製品別、流通経路別

• 英文タイトル:Diabetes Devices Market (Product Type - Glucose Monitoring Devices (Self-monitoring Blood Glucose Meters, Blood Glucose Testing Strips, Lancets, and Continuous Glucose Monitoring Devices), Insulin Delivery Devices (Insulin Syringes, Insulin Pens, and Insulin Pumps), Diabetes Monitoring Software, and Artificial Pancreas System; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Diabetes Clinics/Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Transparency Market Researchが調査・発行した産業分析レポートです。糖尿病治療器具の世界市場分析・規模・シェア・成長・動向・予測:製品別、流通経路別 / Diabetes Devices Market (Product Type - Glucose Monitoring Devices (Self-monitoring Blood Glucose Meters, Blood Glucose Testing Strips, Lancets, and Continuous Glucose Monitoring Devices), Insulin Delivery Devices (Insulin Syringes, Insulin Pens, and Insulin Pumps), Diabetes Monitoring Software, and Artificial Pancreas System; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Diabetes Clinics/Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 / TPM-B04108資料のイメージです。• レポートコード:TPM-B04108
• 出版社/出版日:Transparency Market Research / 2017年12月
• レポート形態:英文、PDF、223ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥782,325 (USD5,795)▷ お問い合わせ
  Multi User¥1,187,325 (USD8,795)▷ お問い合わせ
  Global Site License¥1,592,325 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、糖尿病治療器具の世界市場について調べ、糖尿病治療器具の世界規模、市場動向、市場環境、製品別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・糖尿病治療器具の世界市場動向
・糖尿病治療器具の世界市場環境
・糖尿病治療器具のバリューチェーン分析
・糖尿病治療器具の世界市場規模
・糖尿病治療器具の世界市場規模:製品別
・糖尿病治療器具の世界市場規模:流通経路別
・糖尿病治療器具の世界市場:地域別市場規模・分析
・糖尿病治療器具の北米市場規模・予測
・糖尿病治療器具のアメリカ市場規模・予測
・糖尿病治療器具の中南米市場規模・予測
・糖尿病治療器具のヨーロッパ市場規模・予測
・糖尿病治療器具のアジア市場規模・予測
・糖尿病治療器具の日本市場規模・予測
・糖尿病治療器具の中国市場規模・予測
・糖尿病治療器具のインド市場規模・予測
・糖尿病治療器具の中東市場規模・予測
・糖尿病治療器具のアフリカ市場規模・予測
・競争状況・関連企業情報

Global Diabetes Devices Market: Scope and Methodology

This report on the global diabetes devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global diabetes devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global diabetes devices market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of various segments of global optometry market.

Diabetes Devices Market: Segmentation

Diabetes Mellitus is a chronic condition in which our body is unable to produce or utilize insulin for converting blood glucose into energy. Globally around 415 million people are living with diabetes. Half of the world’s population suffering with diabetes still remains undiagnosed. It is studied that 90% of diabetes cases are of type 2 diabetes. The diabetes devices market has a huge scope during the forecast period. The global diabetes devices market can be segmented based on product type, distribution channel and region.

Depending on the product type the global diabetes devices market includes Glucose Monitoring Devices, Insulin Delivery Devices, Diabetes Monitoring Software and Artificial Pancreas System. The Glucose Monitoring Devices includes four main sub-segments viz. self -monitoring blood glucose meters, blood glucose testing strips, lancets and continuous glucose monitoring meters. Insulin delivery devices segment includes insulin syringes, insulin pens and insulin pumps. The Glucose Monitoring Devices segment is projected to be a highly attractive segment of the global diabetes devices market during the forecast period. The segment is anticipated to be expand at a CAGR of 6.7% during the forecast period. Self- monitoring blood glucose meters segment contributes maximum share to the global diabetes devices market in terms of revenue. High prevalence of diabetes due to factors such as lifestyle changes, high life expectancy and increased urbanization drives this segment of the Diabetes Devices market as people have become more careful about their health conditions and thus regularly monitor their blood glucose levels.

Based on the distribution channel, the global diabetes devices market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and diabetes clinics/centers. The hospital pharmacy segment contributes maximum share in terms of revenue in the forecast period.

Diabetes Devices Market: Geographical and Competitive Dynamics

Geographically, the global diabetes devices market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the diabetes devices market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Medtronic plc, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd.

Global diabetes devices market is segmented as follows:

Global Diabetes Devices Market Revenue, by Product Type

Glucose Monitoring Devices
Self- monitoring blood glucose meters
Blood glucose testing strips
Lancets
Continuous glucose monitoring meters
Insulin Delivery Devices
Insulin syringes
Insulin pens
Insulin pumps
Diabetes Management Software
Artificial Pancreas System
Global Diabetes Devices Market Revenue, by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Diabetes Clinics/ Centres
Global Diabetes Devices Market Revenue, by Region

North America
US
Canada
Europe
Germany
France
Italy
Spain
UK
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Mexico
Rest of Latin America

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Diabetes Device Market

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Diabetes Device Market Analysis and Forecasts, 2017–2025
4.6. Porter’s Five Force Analysis
4.7. Value Chain Analysis
4.8. Estimated Number of People with Diabetes Worldwide and Per Region in 2015 and 2040 (Age 20-79 years)
4.9. Emerging Technologies in Diabetes Management

5. Global Diabetes Device Market Analysis and Forecasts, By Product Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Product Type , 2017–2025
5.4.1. Glucose monitoring devices
5.4.1.1. Self-monitoring blood glucose meters
5.4.1.2. Blood glucose testing strips
5.4.1.3. Lancets
5.4.1.4. Continuous glucose monitoring meters
5.4.2. Insulin Delivery Devices
5.4.2.1. Insulin Syringes
5.4.2.2. Insulin Pens
5.4.2.3. Insulin Pumps
5.4.3. Diabetes Monitoring Software
5.4.4. Artificial Pancreas Systems
5.5. Product Type Comparison Matrix
5.6. Market Attractiveness By Product Type

6. Global Diabetes Device Market Analysis and Forecasts, By Distribution Channel
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast By Distribution Channel , 2017–2025
6.4.1. Hospital Pharmacy
6.4.2. Retail Pharmacy
6.4.3. Online Pharmacy
6.4.4. Diabetes Clinics/ Centers
6.5. Distribution Channel Comparison Matrix
6.6. Market Attractiveness By Distribution Channel

7. Global Diabetes Device Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Policies and Regulations
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Middle East & Africa
7.3.5. Latin America
7.4. Market Attractiveness By Country/Region

8. North America Diabetes Device Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.1.2. Key Trends
8.2. Market Value Forecast By Product Type , 2017–2025
8.2.1. Glucose monitoring devices
8.2.1.1. Self-monitoring blood glucose meters
8.2.1.2. Blood glucose testing strips
8.2.1.3. Lancets
8.2.1.4. Continuous glucose monitoring meters
8.2.2. Insulin Delivery Devices
8.2.2.1. Insulin Syringes
8.2.2.2. Insulin Pens
8.2.2.3. Insulin Pumps
8.2.3. Diabetes Monitoring Software
8.2.4. Artificial Pancreas Systems
8.3. Market Value Forecast By Distribution Channel , 2017–2025
8.3.1. Hospital Pharmacy
8.3.2. Retail Pharmacy
8.3.3. Online Pharmacy
8.3.4. Diabetes Clinics/ Centers
8.4. Market Value Forecast By Country , 2017–2025
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product Type
8.5.2. By Distribution Channel
8.5.3. By Country

9. Europe Diabetes Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Key Trends
9.2. Market Value Forecast By Product Type , 2017–2025
9.2.1. Glucose monitoring devices
9.2.1.1. Self-monitoring blood glucose meters
9.2.1.2. Blood glucose testing strips
9.2.1.3. Lancets
9.2.1.4. Continuous glucose monitoring meters
9.2.2. Insulin Delivery Devices
9.2.2.1. Insulin Syringes
9.2.2.2. Insulin Pens
9.2.2.3. Insulin Pumps
9.2.3. Diabetes Monitoring Software
9.2.4. Artificial Pancreas Systems
9.3. Market Value Forecast By Distribution Channel , 2017–2025
9.3.1. Hospital Pharmacy
9.3.2. Retail Pharmacy
9.3.3. Online Pharmacy
9.3.4. Diabetes Clinics/ Centers
9.4. Market Value Forecast By Country , 2017–2025
9.4.1. Germany
9.4.2. France
9.4.3. Italy
9.4.4. Spain
9.4.5. U.K.
9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Distribution Channel
9.5.3. By Country

10. Asia Pacific Diabetes Device Market Analysis and Forecast
10.1. Introduction
10.1.2. Key Trends
10.2. Market Value Forecast By Product Type , 2017–2025
10.2.1. Glucose monitoring devices
10.2.1.1. Self-monitoring blood glucose meters
10.2.1.2. Blood glucose testing strips
10.2.1.3. Lancets
10.2.1.4. Continuous glucose monitoring meters
10.2.2. Insulin Delivery Devices
10.2.2.1. Insulin Syringes
10.2.2.2. Insulin Pens
10.2.2.3. Insulin Pumps
10.2.3. Diabetes Monitoring Software
10.2.4. Artificial Pancreas Systems
10.3. Market Value Forecast By Distribution Channel , 2017–2025
10.3.1. Hospital Pharmacy
10.3.2. Retail Pharmacy
10.3.3. Online Pharmacy
10.3.4. Diabetes Clinics/ Centers
10.4. Market Value Forecast By Country , 2017–2025
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Distribution Channel
10.5.3. By Country

11. Middle East & Africa Diabetes Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Key Trends
11.2. Market Value Forecast By Product Type, 2017–2025
11.2.1. Glucose monitoring devices
11.2.1.1. Self-monitoring blood glucose meters
11.2.1.2. Blood glucose testing strips
11.2.1.3. Lancets
11.2.1.4. Continuous glucose monitoring meters
11.2.2. Insulin Delivery Devices
11.2.2.1. Insulin Syringes
11.2.2.2. Insulin Pens
11.2.2.3. Insulin Pumps
11.2.3. Diabetes Monitoring Software
11.2.4. Artificial Pancreas Systems
11.3. Market Value Forecast By Distribution Channel, 2017–2025
11.3.1. Hospital Pharmacy
11.3.2. Retail Pharmacy
11.3.3. Online Pharmacy
11.3.4. Diabetes Clinics/ Centers
11.4. Market Value Forecast By Country, 2017–2025
11.4.1. GCC Countries
11.4.2. South Africa
11.4.3. Rest of MEA
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Distribution Channel
11.5.3. By Country

12. Latin America Diabetes Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Key Trends
12.2. Market Value Forecast By Product Type, 2017–2025
12.2.1. Glucose monitoring devices
12.2.1.1. Self-monitoring blood glucose meters
12.2.1.2. Blood glucose testing strips
12.2.1.3. Lancets
12.2.1.4. Continuous glucose monitoring meters
12.2.2. Insulin Delivery Devices
12.2.2.1. Insulin Syringes
12.2.2.2. Insulin Pens
12.2.2.3. Insulin Pumps
12.2.3. Diabetes Monitoring Software
12.2.4. Artificial Pancreas Systems
12.3. Market Value Forecast By Distribution Channel, 2017–2025
12.3.1. Hospital Pharmacy
12.3.2. Retail Pharmacy
12.3.3. Online Pharmacy
12.3.4. Diabetes Clinics/ Centers
12.4. Market Value Forecast By Country, 2017–2025
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Distribution Channel
12.5.3. By Country

13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.2.1. Medtronic
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Financial Overview
13.2.1.3. Product Portfolio
13.2.1.4. SWOT Analysis
13.2.1.5. Strategic Overview
13.2.2. Novo Nordisk A/S
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Financial Overview
13.2.2.3. Product Portfolio
13.2.2.4. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3. Sanofi
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Financial Overview
13.2.3.3. Product Portfolio
13.2.3.4. SWOT Analysis
13.2.3.5. Strategic Overview
13.2.4. Eli Lilly and Company
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Financial Overview
13.2.4.3. Product Portfolio
13.2.4.4. SWOT Analysis
13.2.4.5. Strategic Overview
13.2.5. F. Hoffmann-La Roche Ltd.
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Financial Overview
13.2.5.3. Product Portfolio
13.2.5.4. SWOT Analysis
13.2.5.5. Strategic Overview
13.2.6. Becton, Dickinson and Company
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Financial Overview
13.2.6.3. Product Portfolio
13.2.6.4. SWOT Analysis
13.2.6.5. Strategic Overview
13.2.7. Tandem Diabetes Care, Inc.
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Financial Overview
13.2.7.3. Product Portfolio
13.2.7.4. SWOT Analysis
13.2.7.5. Strategic Overview
13.2.8. Abbott Laboratories
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Financial Overview
13.2.8.3. Product Portfolio
13.2.8.4. SWOT Analysis
13.2.8.5. Strategic Overview
13.2.9. Cellnovo
13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.9.2. Financial Overview
13.2.9.3. Product Portfolio
13.2.9.4. SWOT Analysis
13.2.9.5. Strategic Overview
13.2.10. Insulet Corporation
13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.10.2. Financial Overview
13.2.10.3. Product Portfolio
13.2.10.4. SWOT Analysis
13.2.10.5. Strategic Overview
13.2.11. LifeScan, Inc.
13.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.11.2. Financial Overview
13.2.11.3. Product Portfolio
13.2.11.4. SWOT Analysis
13.2.11.5. Strategic Overview
13.2.12. Owen Mumford Ltd.
13.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.12.2. Financial Overview
13.2.12.3. Product Portfolio
13.2.12.4. SWOT Analysis
13.2.12.5. Strategic Overview

List of Tables

Table 01: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product type, 2015–2025
Table 02: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices 2015–2025
Table 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type– Insulin Delivery Devices, 2015–2025
Table 04: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 05: Global Insulin Delivery Devices Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 07: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 08: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices 2015–2025
Table 09: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type– Insulin Delivery Devices, 2015–2025
Table 10: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 11: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 12: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 13: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices, 2015–2025
Table 14: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2015–2025
Table 15: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 18: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2015–2025
Table 19: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2015–2025
Table 20: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 21: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by product type, 2015–2025
Table 23: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2015–2025
Table 24: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2015–2025
Table 25: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 26: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 27: Middle East & Africa Market Size (US$ Mn) Forecast, by product type, 2015–2025
Table 28: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2015–2025
Table 29: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2015–2025
Table 30: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025